Center for Enteric Diseases in Engineered Tissues
Center for Enteric Diseases in Engineered Tissues
批准号:
9467425
负责人:
Ralph R. Isberg
金额:
$160.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-07 至 2022-03-31
关键词:
3-DimensionalAddressAnaerobic BacteriaAnimal ModelAnimalsAnti-Infective AgentsApicalBacteriaBiochemicalBiological AssayBiological ModelsBiomedical EngineeringBostonCause of DeathCell CommunicationCellsClinicClinicalClostridium difficileCollaborationsCommunicable DiseasesCommunicationCommunitiesComplexControlled EnvironmentCryptococcusCryptosporidiumCryptosporidium parvumDataDevelopmentDimensionsDiseaseDrug ScreeningEngineeringEnsureEnteralEnvironmentEpitheliumEventExposure toFaceGastroenterologistGastroenterologyGene ExpressionGeneticGoalsHumanHuman MicrobiomeHypoxiaImmuneIn VitroIndividualInfectionIntegration Host FactorsIntestinesInvestigationMedicalMedical centerMetabolicMethodsMicrobeMicrobial PhysiologyModelingMorbidity - disease rateMucous MembraneOffice of Administrative ManagementOrganOrganismOutcomeOxygenParasitesPathogenesisPathogenicityPatientsPhysiologicalProcessPropertyResearchResearch PersonnelSamplingSiteSpecialistStructureSystemTherapeuticTissue EngineeringTissue ModelTissuesUniversitiesVibrio choleraeVisionWorkYersiniaantimicrobialantimicrobial drugassay developmentbaseclinical materialcohortdesignenteric pathogenexperimental analysishost colonizationhuman diseasehuman microbiotahuman modelhuman tissueimprovedin vitro Modelinnovationinterestmembermicrobial hostmicroorganismmicroorganism interactionmortalitynovelnovel strategiespathogenprogramsscreeningsymposiumsynergismthree-dimensional modelingtissue culturetissue support frame
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Enteric infectious diseases are important causes of morbidity and mortality worldwide, with diarrheal diseases
being among the leading causes of death in the young. Detailed understanding of the interaction between
enteropathogens and the human host is limited due to the inaccessibility of pathogens while growing within
host tissues. Workers generally reconstruct human disease events using animal infection and tissue culture-
based models to analyze the pathogen-host interface. Human diseases, however, are often poorly reproduced
in animal models, while tissue culture models lack the complexity to fully reconstruct events during disease that
bring in a complex group of host cells. To address these issues and provide more physiologically relevant
models for use by workers studying enteropathogenesis, this application proposes a Center on Enteric
Diseases in Engineered Tissues (CEDET) to generate bioengineered three-dimensional models of human
tissue derived from human clinical intestinal cells. The engineered tissues developed by the CEDET team will
be challenged directly with enteropathogens in a quest to develop analytic strategies that more accurately
mimic events that occur in the human host compared to work in known tissue culture models.
The CEDET brings investigators from the Engineering and Medical campuses of Tufts University together with
a gastroenterologist to focus on identifying new strategies for analyzing the interface between enteropathogens
and intestinal cells of clinical origin. The proposed CEDET will develop engineered tissue platforms for
pathogens having specific metabolic requirements, described as individual but synergizing projects. In Project
1, the engineered tissues will be used to generate a model system in which the apical and basal faces of the
epithelium will be exposed to different O2 tensions, to allow the study of Clostridium difficile, a strict anaerobic
organism. Project 2 will develop a 3D in vitro tissue model of the human intestine tunica mucosa and study
infections of human epithelium by Vibrio cholera and enteropathogenic Yersinia spp. This Project will allow the
development of a tractable 3D human intestinal tissue model system for studying the specific mechanistic
steps that are important for enteric pathogens to successfully colonize the host intestine. Finally, in Project 3,
the 3D intestinal models will be used to overcome the technical hurdle of developing a system for continuous
propagation of Cryptococcus, investigation of host-parasite interactions in primary human cells and a system
for drug screening recapitulating human gut structure. Each of the Projects is driven by Aims that propose to
construct artificial tissues of increasing complexity, bringing in immune cells, primary cells derived from
endoscopic isolation in the clinic, and human microbiome samples in O2-controlled environments. The entire
Center will be driven by Administrative and Scientific Cores, which have the express purpose of supporting
synergy between the individual Projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The interface between L. pneumophila manipulation of host endoplasmic reticulum and innate immune subterfuge
-
批准号:10331320
-
项目类别:
-
资助金额:$66.14万
-
财政年份:2020
-
负责人:Ralph R. Isberg
-
依托单位:
Molecular basis of metal acquisition by an intravacuolar pathogen
-
批准号:10259847
-
项目类别:
-
资助金额:$69.48万
-
财政年份:2020
-
负责人:Ralph R. Isberg
-
依托单位:
Molecular basis of metal acquisition by an intravacuolar pathogen
-
批准号:10033724
-
项目类别:
-
资助金额:$64.6万
-
财政年份:2020
-
负责人:Ralph R. Isberg
-
依托单位:
Molecular basis of metal acquisition by an intravacuolar pathogen
-
批准号:10444928
-
项目类别:
-
资助金额:$68.98万
-
财政年份:2020
-
负责人:Ralph R. Isberg
-
依托单位:
Molecular basis of metal acquisition by an intravacuolar pathogen
-
批准号:10646234
-
项目类别:
-
资助金额:$69.12万
-
财政年份:2020
-
负责人:Ralph R. Isberg
-
依托单位:
The interface between L. pneumophila manipulation of host endoplasmic reticulum and innate immune subterfuge
-
批准号:10554261
-
项目类别:
-
资助金额:$66.14万
-
财政年份:2020
-
负责人:Ralph R. Isberg
-
依托单位:
Engineering of Complex Infectious Loci in Culture
-
批准号:10092952
-
项目类别:
-
资助金额:$20.04万
-
财政年份:2020
-
负责人:Ralph R. Isberg
-
依托单位:
Center for Enteric Diseases in Engineered Tissues
-
批准号:9312409
-
项目类别:
-
资助金额:$165.67万
-
财政年份:2017
-
负责人:Ralph R. Isberg
-
依托单位:
Administrative Core
-
批准号:9312410
-
项目类别:
-
资助金额:$6.58万
-
财政年份:2017
-
负责人:Ralph R. Isberg
-
依托单位:
Center for Enteric Diseases in Engineered Tissues
-
批准号:9893783
-
项目类别:
-
资助金额:$163.08万
-
财政年份:2017
-
负责人:Ralph R. Isberg
-
依托单位:
Control of Endoplasmic Reticulum Tubule Formation by Legionella pneumophila
-
批准号:8764953
-
项目类别:
-
资助金额:$49.56万
-
财政年份:2014
-
负责人:Ralph R. Isberg
-
依托单位:
Control of Endoplasmic Reticulum Tubule Formation by Legionella pneumophila
-
批准号:9277999
-
项目类别:
-
资助金额:$59.19万
-
财政年份:2014
-
负责人:Ralph R. Isberg
-
依托单位:
Mammalian cell collaboration with bacterial type III secretion
-
批准号:8899077
-
项目类别:
-
资助金额:$40.19万
-
财政年份:2014
-
负责人:Ralph R. Isberg
-
依托单位:
Control of Endoplasmic Reticulum Tubule Formation by Legionella pneumophila
-
批准号:8856133
-
项目类别:
-
资助金额:$49.56万
-
财政年份:2014
-
负责人:Ralph R. Isberg
-
依托单位:
Analysis of the interplay between cell adhesion and bacterial protein translocati
-
批准号:8225806
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2012
-
负责人:Ralph R. Isberg
-
依托单位:
Analysis of the interplay between cell adhesion and bacterial protein translocati
-
批准号:8418697
-
项目类别:
-
资助金额:$20.63万
-
财政年份:2012
-
负责人:Ralph R. Isberg
-
依托单位:
2012 Microbial Toxins & Pathogenicity Gordon Research Conference & Gordon Researc
-
批准号:8308744
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2012
-
负责人:Ralph R. Isberg
-
依托单位:
Host Protein Modulation of Type III Secretion
-
批准号:8018596
-
项目类别:
-
资助金额:$20.63万
-
财政年份:2010
-
负责人:Ralph R. Isberg
-
依托单位:
Host Protein Modulation of Type III Secretion
-
批准号:7774048
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2010
-
负责人:Ralph R. Isberg
-
依托单位:
BIOLOGICAL REGULATORY MECHANISMS
-
批准号:2077096
-
项目类别:
-
资助金额:$0.21万
-
财政年份:1996
-
负责人:Ralph R. Isberg
-
依托单位:
海外基金